Resources: Publications

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Cell Biology
Immunology
Oncology

Scalable Longitudinal Imaging and Transcriptomics of Cells in Dynamic Enclosures

In this bioRxiv preprint, Khurana et al., Cellanome introduces a scalable platform for longitudinal imaging and single-cell transcriptomics. Utilizing light-guided hydrogel CellCage Enclosures (CCEs), the system links real-time cellular behavior and morphological trajectories to whole-transcriptome profiles in adherent and suspension cells. The authors conclude that this platform transforms single-cell analysis from a static snapshot into a causal framework. By providing a substrate for longitudinal observation of the same individual cells that are eventually sequenced, the technology enables the construction of higher-fidelity virtual cell models and a deeper understanding of stochastic cellular adaptation in disease.
BioRxiv
May 5, 2026
Cell Biology
Immunology

Linking live-cell behavior to transcriptional responses across perturbations using dynamic caging

This preprint, by Orcutt-Jahns et al., introduces a methodology for pairing live-cell imaging with terminal transcriptomics. By utilizing CellCage Enclosures (CCE), the authors address the "unpaired data" limitation in single-cell biology, allowing for the direct mapping of a cell’s longitudinal physical behavior to its genetic state. The study demonstrates that deterministic linkage of live-cell behavior and transcriptomics can uncover regulatory mechanisms, such as the relationship between cytoskeletal state and immune signaling, that are not detectable through population-level inference or single-modality assays.
BioRxiv
May 5, 2026
Oncology

Leveraging a novel, multi-modal platform to identify drug resistant clones with distinct mechanisms of resistance to EGFR inhibitors

This study introduces Cellanome’s R3200 platform, a high-throughput technology designed to bridge the gap between live-cell behavior and molecular profiling. By utilizing semi-permeable CellCage Enclosures (CCEs), researchers tracked tens of thousands of individual A549 lung cancer cells treated with EGFR inhibitors (Olmutinib) and antibody-drug conjugates (Cetuximab-MMAE).
Journal for Immunotherapy of Cancer
November 25, 2025
See More

Let's talk about your experiments

Tell us a bit about your work, and we’ll set up time for you to speak with a team member who’s seen something similar.

Get in Touch

Your message has been sent successfully!

Thank you for reaching out to us. Our team will be in touch with you shortly.

Oops! Something went wrong while submitting the form.